METHODS: Data were collected from one Facebook group via posts and comments referencing TMR. Posts published between January 1, 2020, and March 24, 2023 were analyzed. Data collected included pain prior to surgery, pain in immediate post-op period, and change in pain after surgery.
RESULTS: Forty-three individuals commented on their TMR experience. Among them, 31 had favorable surgical outcomes, 7 felt that the surgery worsened their pain or there was no significant change in their pain levels, and 5 commented during the initial post-operative period. Twenty-four patients described their pain in the immediate post-operative period and all patients said that the post-operative pain was worse than chronic pain. Among the 28 authors who commented on overall reduction in chronic pain, 24 reported that TMR reduced their pain, whereas 4 reported no change or worsened pain.
CONCLUSIONS: The number of patients (24) who reported improvement in chronic pain aligns with the results in current literature suggesting that TMR is a viable treatment option for pain management. With the current medical management of similar conditions, up to 80% of patients remain unsatisfied with pain management. This analysis supports the evidence that TMR is an effective treatment for patients experiencing post-amputation pain.
方法:通过引用TMR的帖子和评论从一个Facebook小组收集数据。分析了2020年1月1日至2023年3月24日之间发布的帖子。收集的数据包括手术前的疼痛,术后即刻疼痛,以及手术后疼痛的变化。
结果:43个人评论了他们的TMR经历。其中,31例具有良好的手术效果,7认为手术使他们的疼痛恶化,或者他们的疼痛水平没有明显变化,和5评论在最初的术后期间。24名患者描述了术后即刻的疼痛,所有患者都说术后疼痛比慢性疼痛更严重。在28位评论慢性疼痛总体减少的作者中,24报告说TMR减轻了他们的痛苦,而4例报告疼痛无变化或恶化。
结论:报告慢性疼痛改善的患者数量(24例)与当前文献中的结果一致,这些结果提示TMR是疼痛管理的可行治疗选择。与目前医疗管理类似的情况,高达80%的患者仍然对疼痛管理不满意。该分析支持TMR是截肢后疼痛患者的有效治疗方法的证据。